Source-grounded facts extracted from American Healthcare REIT, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
American Healthcare REIT, Inc. reported first quarter 2026 results: net income $23.7 million, or $0.13 per diluted share, EPS $0.13 per diluted share. Guidance raised.
“Reported GAAP net income attributable to controlling interest of $23.7 million, or $0.13 per diluted share, for the three months ended March 31, 2026.”
American Healthcare REIT, Inc. amended credit facility of up to $1,850,000,000 with Bank of America, N.A. at Daily Simple SOFR plus the Applicable Rate for Daily SOFR Rate Loans or Term SOF maturing Revolving Loans that mature on April 1, 2030, with two extension options ... and Term Loans that mature on January 19, 2027.
“be increased by an aggregate incremental amount such that after giving effect thereto, the maximum aggregate amount of Term Loans and available Revolving Loans does not exceed $1,850,000,000, subject to: (i) the terms of the 2026 Credit Agreement; and (ii) at least five business days’ prior written notice to Bank of America. The 2026 Credit Facility bears interest at”
American Healthcare REIT, Inc. entered into ATM Equity Offering Sales Agreement with BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Truist Securiti valued at up to $1.75 billion (effective 2026-02-27).
“On February 27, 2026, we and American Healthcare REIT Holdings, LP, or our Operating Partnership, entered into an ATM Equity Offering Sales Agreement, or the Sales Agreement, with BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Truist Securities, Inc., or each, an Agent, and, collectively, the Agents, and the Forward Purchasers (as defined below), providing for the offer and sale of shares of our common stock, $0.01 par value per share, or Common Stock, having an aggregate gross sales price of up to $1.75 billion”
American Healthcare REIT, Inc.: Amended Bylaws to grant stockholders the power to adopt, alter or repeal any provision of the Bylaws upon a majority vote (effective 2025-02-21).
“our board of directors, or our Board, approved and adopted the Second Amended and Restated Bylaws, or the Bylaws, which became effective upon adoption by our Board, to amend Article XIV of the Bylaws to provide stockholders with the power to adopt, alter or repeal any provision of the Bylaws and to make new Bylaws upon the affirmative vote of not less than a majority of all the votes entitled to be cast on the matter”
American Healthcare REIT, Inc. reported the three months ended March 31, 2024 results: EPS $(0.04) per basic and diluted share.
“Reported GAAP net loss attributable to common stockholders of $(0.04) per basic and diluted share for the three months ended March 31, 2024.”
American Healthcare REIT, Inc. updated its year ending December 31, 2024 guidance (initiated).
“The Company has established the following guidance ranges for the year ending December 31, 2024: Full Year 2024 Guidance Metric FY 2023 Actual FY 2024 Range FY 2024 Midpoint NAREIT FFO per share Normalized FFO per share Total Portfolio SS NOI Growth: $0.99 $1.40 8.6% $1.13 to $1.19 $1.18 to $1.24 5.0% to 7.0% $1.16 $1.21 6.0%”
American Healthcare REIT, Inc. reported financial results for year ended December 31, 2023.
“Total Portfolio Same-Store Net Operating Income (“NOI”) growth of 8.6%, highlighted by 27.2% and 14.0% Same-Store NOI growth from our SHOP and Integrated Senior Health Campuses (“ISHC”), respectively.”
American Healthcare REIT, Inc. reported 12 months ended December 31, 2023 results: EPS $(1.08) per basic and diluted share.
“Reported GAAP net loss attributable to stockholders of $(0.42) and $(1.08) per basic and diluted share for the three and 12 months ended December 31, 2023.”
American Healthcare REIT, Inc. reported three months ended December 31, 2023 results: EPS $(0.42) per basic and diluted share.
“Reported GAAP net loss attributable to stockholders of $(0.42) and $(1.08) per basic and diluted share for the three and 12 months ended December 31, 2023.”
American Healthcare REIT, Inc. updated its fourth quarter 2023 and full year 2023 guidance (initiated).
“American Healthcare REIT (“AHR”) Announces Fourth Quarter 2023 and Full Year 2023 Results; Issues Full Year 2024 Guidance”
American Healthcare REIT, Inc. amended credit facility of aggregate maximum principal amount up to $1,150,000,000 with Bank of America, N.A. at Daily Simple Secured Overnight Financing Rate, or Daily SOFR, plus the Applicabl maturing February 14, 2028 for Revolving Loans; January 19, 2027 for Term Loan.
“as a joint lead arranger and sole bookrunner for the revolving facility and the term loan facility, to obtain a credit facility with an aggregate maximum principal amount up to $1,150,000,000, or the 2024 Credit Facility. The 2024 Credit Facility consists of a senior unsecured revolving credit facility in the initial aggregate amount of $600,000,000 and a senior”
American Healthcare REIT, Inc.: Articles Supplementary filed to prohibit the company from electing to be subject to Section 3-803 of the MGCL (the Maryland Unsolicited Takeovers Act) unless approved by stockholders (effective 2024-02-07).
“On February 7, 2024, we filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland, which prohibit us from unilaterally electing to be subject to Section 3-803 of Title 3, Subtitle 8 of the Maryland General Corporation Law (the "MGCL"), commonly referred to as the Maryland Unsolicited Takeovers Act ("MUTA").”
American Healthcare REIT, Inc. entered into Underwriting Agreement with BofA Securities, Inc. and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein (effective 2024-02-06).
“we entered into an Underwriting Agreement, dated February 6, 2024, by and among us, American Healthcare REIT Holdings, LP (the "Operating Partnership"), BofA Securities, Inc. and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein”
American Healthcare REIT, Inc.: Board of directors reclassified and designated 700,000,000 authorized but unissued shares of Class I Common Stock as authorized but unissued shares of common stock without class or series designation, effective January 26, 2024 (effective 2024-01-26).
“In connection with the Proposed Listing, effective January 26, 2024, our board of directors reclassified and designated 700,000,000 authorized but unissued shares of Class I Common Stock, $0.01 par value per share, as authorized but unissued shares of common stock, $0.01 par value per share, or the Common Stock, without any designation as to class or series, by filing Articles Supplementary with the State Department of Assessments and Taxation of Maryland.”
American Healthcare REIT, Inc. entered into Membership Interest Purchase Agreement with NorthStar Healthcare Income Operating Partnership, LP and its subsidiary Trilogy Holdings NT-HCI, LLC valued at $240.5 million (effective 2023-11-03).
“On November 3, 2023 (the “Agreement Date”), American Healthcare REIT, Inc. (“we”) and our subsidiary GAHC3 Trilogy JV, LLC (“Buyer”) entered into a Membership Interest Purchase Agreement (the “Option Agreement”) with NorthStar Healthcare Income Operating Partnership, LP and its subsidiary Trilogy Holdings NT-HCI, LLC (“Seller”).”
American Healthcare REIT, Inc. shareholders approved Approval of the American Healthcare REIT, Inc. Second Amended and Restated 2015 Incentive Plan. at the 2023-06-15 meeting.
“The American Healthcare REIT, Inc. Second Amended and Restated 2015 Incentive Plan therefore was approved by the requisite vote of our stockholders.”
American Healthcare REIT, Inc. shareholders approved Advisory (non-binding) approval of the compensation paid to our named executive officers for the year ended December 31, 2022. at the 2023-06-15 meeting.
“The compensation of our named executive officers therefore was approved by the requisite vote of our stockholders, on an advisory basis.”
American Healthcare REIT, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2023. at the 2023-06-15 meeting.
“The appointment of Deloitte & Touche as our independent registered public accounting firm for the year ending December 31, 2023, therefore was ratified by the requisite vote of our stockholders necessary for approval.”
American Healthcare REIT, Inc. shareholders approved Election of nine directors, each to hold office for a one-year term expiring at the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies. at the 2023-06-15 meeting.
“On June 15, 2023, we held our 2023 Annual Meeting of Stockholders.”
J. Grayson Sanders departed as independent director at American Healthcare REIT, Inc..
“On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.”
Gerald W. Robinson departed as independent director at American Healthcare REIT, Inc..
“On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.”
Harold H. Greene departed as independent director at American Healthcare REIT, Inc..
“On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.”
American Healthcare REIT, Inc. amended credit facility of up to $1,050,000,000 with Bank of America, N.A., as administrative agent.
“Credit Agreement, with Bank of America, N.A., or Bank of America, and the lenders named thereto, to obtain a credit facility with an aggregate maximum principal amount up to $1,050,000,000, or the 2022 Credit Facility. On March 1, 2023, we entered into an amendment to the 2022 Amended and Restated Credit Agreement, or the First Amendment, with Bank of America, as”
American Healthcare REIT, Inc.: Amended and restated bylaws to update stockholder meeting provisions for compliance with federal proxy rules, including proxy card color, director nomination information, and Rule 14a-19 compliance (effective 2023-02-17).
“On February 17, 2023, our board of directors, or our Board, approved and adopted amended and restated bylaws, or our Bylaws, to, among other things, update provisions relating to stockholder meetings to ensure compliance with federal proxy rules, including Rule 14a-19 under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Our Bylaws became effective upon adoption by our Board.”
Valerie Richardson was appointed as Director at American Healthcare REIT, Inc..
“increased the size of our Board to 12 members and appointed Marvin R. O’Quinn and Valerie Richardson to fill the two outstanding vacancies on our Board effective January 10, 2023.”
Marvin R. O’Quinn was appointed as Director at American Healthcare REIT, Inc..
“increased the size of our Board to 12 members and appointed Marvin R. O’Quinn and Valerie Richardson to fill the two outstanding vacancies on our Board effective January 10, 2023.”
American Healthcare REIT, Inc.: Implemented a 1-for-4 reverse stock split and decreased par value from $0.04 to $0.01 per share via charter amendments (effective 2022-11-15).
“In connection with the Proposed Listing, on November 15, 2022, we effected a one-for-four reverse stock split, or the Reverse Stock Split, of each issued and outstanding share of Class T common stock, par value $0.01 per share, and Class I common stock, par value $0.01 per share, or our Common Stock, by filing articles of amendment to our charter, or the Stock Split Amendment. As a result of the Reverse Stock Split, every four shares of issued and outstanding Common Stock were combined and converted into one new share of the respective class of Common Stock, par value $0.04 per share. Additionally, immediately following the Reverse Stock Split, we also filed articles of amendment to our charter to decrease the par value of each share of our Common Stock outstanding as a result of the Reverse Stock Split from $0.04 per share to $0.01 per share, or the Par Value Decrease Amendment.”
Scott A. Estes was appointed as director at American Healthcare REIT, Inc..
“On August 30, 2022, our board of directors, or our Board, increased the size of our Board to ten members and appointed Scott A. Estes to fill the outstanding vacancy on our Board and serve as a director of our company and a member of the audit committee of our Board, or our Audit Committee.”
Gabriel M. Willhite was appointed as Chief Operating Officer at American Healthcare REIT, Inc..
“our board of directors appointed Gabriel M. Willhite, age 41 , as our Chief Operating Officer effective August 1, 2022.”
Mathieu B. Streiff retired as Executive Vice President at American Healthcare REIT, Inc..
“Mathieu B. Streiff informed our board of directors of his intention to transition from his position as Chief Operating Officer to Executive Vice President effective August 1, 2022, and then to retire from that position effective January 1, 2023 .”
Mathieu B. Streiff changed role as Chief Operating Officer at American Healthcare REIT, Inc..
“Mathieu B. Streiff informed our board of directors of his intention to transition from his position as Chief Operating Officer to Executive Vice President effective August 1, 2022, and then to retire from that position effective January 1, 2023 .”
Brian S. Peay was appointed as other_named_officer at American Healthcare REIT, Inc..
“the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.”
Mathieu B. Streiff was appointed as other_named_officer at American Healthcare REIT, Inc..
“the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.”
Danny Prosky was appointed as other_named_officer at American Healthcare REIT, Inc..
“the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.”
Jeffrey T. Hanson was appointed as other_named_officer at American Healthcare REIT, Inc..
“the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.”
Gabriel M. Willhite was appointed as Executive Vice President, General Counsel at American Healthcare REIT, Inc..
“Also effective October 1, 2021, Gabriel M. Willhite was appointed Executive Vice President, General Counsel of the Company, filling the vacancy created by Mr. Streiff’s resignation from such position.”
Mathieu B. Streiff was appointed as Chief Operating Officer at American Healthcare REIT, Inc..
“Also effective October 1, 2021, Gabriel M. Willhite was appointed Executive Vice President, General Counsel of the Company, filling the vacancy created by Mr. Streiff’s resignation from such position.”
Danny Prosky was appointed as Chief Executive Officer at American Healthcare REIT, Inc..
“In addition, effective October 1, 2021, Danny Prosky was appointed Chief Executive Officer of the Company and thereby will no longer serve as Chief Operating Officer of the Company but will continue in the role of President, and Mathieu B. Streiff was appointed Chief Operating Officer of the Company and thereby will no longer serve as Executive Vice President, General Counsel of the Company.”
Jeffrey T. Hanson was appointed as Executive Chairman at American Healthcare REIT, Inc..
“Effective October 1, 2021, Jeffrey T. Hanson was appointed Executive Chairman of the Board of Directors of the Company and thereby will no longer serve as Chief Executive Officer of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.